KPV

KPV, also known as Lysine-Proline-Valine, is a synthetic tripeptide derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). As a bioactive peptide, KPV is recognized for its distinct anti-inflammatory properties and its involvement in modulating immune responses at the molecular level. The sequence's stability and biological activity have made it a subject of considerable interest in biochemical research, particularly in studies focused on peptide signaling, inflammation pathways, and cellular regulatory mechanisms. Its utility as a research tool stems from its ability to interact with specific molecular targets, enabling detailed investigation into the mechanisms underlying inflammation and immune modulation.

Inflammation pathway research: KPV is widely utilized in research exploring the molecular mechanisms of inflammation. Due to its capacity to inhibit pro-inflammatory cytokine production and reduce the activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), the peptide serves as a valuable probe for dissecting the cellular signaling events that govern inflammatory responses. Researchers employ it to delineate the downstream effects of α-MSH derivatives, providing insight into the modulation of key immune mediators and supporting the development of novel anti-inflammatory strategies.

Peptide-receptor interaction studies: The tripeptide is frequently used to investigate the interaction between melanocortin peptides and their cognate receptors. Its selective activity allows for the examination of receptor binding specificity, signal transduction, and the functional consequences of peptide-receptor engagement. Such studies are instrumental in clarifying the structural requirements for receptor activation and in mapping the biological roles of melanocortin-derived fragments within diverse cellular contexts.

Peptide synthesis and analog development: KPV's well-characterized sequence and robust biological profile make it an ideal template for the synthesis of peptide analogs. Researchers leverage its structure to design and evaluate modified peptides with altered stability, receptor affinity, or functional activity. These synthetic efforts facilitate the discovery of new bioactive compounds and support the optimization of peptide-based research tools for a range of experimental applications.

Cellular signaling modulation: The peptide is employed in in vitro models to assess its effects on cellular signaling cascades related to immune regulation. By applying KPV to cultured cells, scientists can monitor changes in transcription factor activity, cytokine expression, and downstream signaling events. These studies contribute to a deeper understanding of how short peptide fragments influence complex cellular networks, offering valuable data for the broader field of immunology and cell biology.

Analytical and assay development: KPV is also used as a reference standard and functional control in the development of analytical assays targeting peptide-mediated pathways. Its defined activity profile supports the calibration of bioassays, the validation of detection methods, and the benchmarking of new analytical platforms. These applications are essential for ensuring the reliability and reproducibility of experimental results in peptide research and for advancing the methodological toolkit available to life science laboratories.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Cationic cell-penetrating peptides are potent furin inhibitors